Overview

Efficacy and Safety Study of P-Gemox vs.EPOCH as First-line Chemotherapy to Treat NK/T-cell Lymphoma With Early Stage

Status:
Terminated

Trial end date:
2017-06-01

Target enrollment:

Participant gender:

Summary

Purpose :To compare the efficacy and and safety of the P-Gemox chemotherapy regimen with those of the EPOCH regimen for stage IE to IIE ENKTL.

Phase:

Phase 3

Details

Lead Sponsor:

Sun Yat-sen University

Treatments:

Asparaginase
Cyclophosphamide
Doxorubicin
Etoposide
Etoposide phosphate
Gemcitabine
Liposomal doxorubicin
Oxaliplatin
Pegaspargase
Prednisone
Vincristine